Bone Marrow TransplantationTransplantation, AutologousBone MarrowTransplantation, HomologousBone Marrow CellsBone Marrow PurgingWhole-Body IrradiationHematopoietic Stem CellsHematopoietic Stem Cell TransplantationGraft vs Host DiseaseCombined Modality TherapyCyclophosphamideLymphoma, Non-HodgkinCarmustineTransplantation ConditioningBusulfanLeukemiaBone and BonesMelphalanRemission InductionAnemia, AplasticGraft SurvivalHematopoiesisAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myeloid, AcuteRecurrenceTransplantation ChimeraEtoposideHodgkin DiseaseColony-Forming Units AssayLiver TransplantationBone Marrow DiseasesTissue DonorsCytarabineTreatment OutcomeLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibility TestingActuarial AnalysisTransplantation, IsogeneicHistocompatibilityStem Cell TransplantationSurvival AnalysisTime FactorsMice, Inbred C57BLAcute DiseaseKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveVincristinePodophyllotoxinRadiation ChimeraLymphomaHematologic NeoplasmsHepatic Veno-Occlusive DiseaseDisease-Free SurvivalSurvival RateSalvage TherapyFollow-Up StudiesImmunosuppressive AgentsImmunosuppressionMyelodysplastic SyndromesDrug EvaluationGranulocyte Colony-Stimulating FactorLeukocyte CountBone Marrow ExaminationRetrospective StudiesStem CellsT-LymphocytesGraft RejectionThiotepaHematologic DiseasesBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsMultiple MyelomaCyclosporineAntigens, CD34Graft vs Host ReactionLymphocyte DepletionCell DifferentiationGranulocytesPrognosisLeukocyte TransfusionSevere Combined ImmunodeficiencyCell SeparationBlood Cell CountHeart TransplantationHLA AntigensHematopoietic Stem Cell MobilizationChimeraAntibodies, MonoclonalPlatelet CountGranulocyte-Macrophage Colony-Stimulating FactorPrednisoneFlow CytometryProspective StudiesMitoxantroneLymphatic IrradiationCells, CulturedLymphocyte Transfusion